Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia

Blood

Volumn 105, Issue 4, 2005, Pages 1797-1802

  Rivera, Seth ^a   Liu, Lide ^a   Nemeth, Elizabeta ^a   Gabayan, Victoria ^a   Sorensen, Ole E ^a   Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC FERROCYANIDE; HEPCIDIN; IRON;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SMEAR; CARCINOMA CELL; CELL STRAIN CACO 2; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; INFLAMMATION; IRON BLOOD LEVEL; IRON INTAKE; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR; TUMOR XENOGRAFT; URINE LEVEL; WESTERN BLOTTING;

EID: 13544252463     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-08-3375     Document Type: Article

References (24)

1. Knight K, Wade S, Balducci L. Prevalence and outcomes of anemia in cancer, a systematic review of the literature. Am J Med. 2004;116(suppl 7A):11S-26S.
2. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004;32:39-52.
3. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis. 1997;25:888-895.
4. Cartwright GE. The anemia of chronic disorders. Semin Hematol. 1966;3:351-375.
5. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol. 1999;70:7-12.
6. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783-788.
7. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-2463.
8. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-1276.
9. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99:4596-4601.
10. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-3781.
11. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-1044.
12. Anderson GJ, Frazer DM, Wilkins SJ, et al. Relationship between intestinal iron-transporter expression, hepatic hepcidin levels and the control of iron absorption. Biochem Soc Trans. 2002;30:724-726.
13. Roy CN, Custodio AO, de Graaf J, et al. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat Genet. 2004;36:481-485.
14. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806-7810.
15. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72:8150-8157.
16. Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet. 1971;1:100-103.
17. Hunter HN, Fulton DB, Ganz T Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem. 2002;277:37597-37603.
18. Zucker S, Friedman S, Lysik RM. Bone marrow erythropoiesis in the anemia of infection, inflammation, and malignancy. J Clin Invest. 1974;53:1132-1138.
19. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180-191.
20. Erslev AJ. Anemia of chronic disease. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. New York, NY: McGraw-Hill Inc; 1999:481-488.
21. Sartor RB, Anderle SK, Rifai N, et al. Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Infect Immun. 1989;57:1177-1185.
22. Zarrabi MH, Lysik R, DiStefano J, Zucker S. The anaemia of chronic disorders: studies of iron reutilization in the anaemia of experimental malignancy and chronic inflammation. Br J Haematol. 1977;35:647-658.
23. Carbonell MT, Saiz MP, Marti MT, Queralt J, Mitjavila MT. Iron mobilizatton in three animal models of inflammation. Rev Esp Pistol. 1989;45:163-170.
24. Miranda CJ, Makui H, Andrews NC, Santos MM. Contributions of beta2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1(-/-) and beta2mRag1(-/-) double knock-out mice. Blood. 2004;103:2847-2849.